IMFINZI 120MG/2.4ML INJECTION

Form: Injection

Pack Size: 1 VIAL (2.4ML)

Marketed by: ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV)

MRP: ₹40790.96

ASTRAZENECA PHARMA INDIA LTD (ONCOLOGY DIV): Imfinzi 120MG/2.4ML Injection, 1 vial (2.4ml), salt durvalumab 120mg/2.4ml. Its MRP stays at Rs 40,790.96 in NPPA's 09-11-2026 anti-cancer trade-margin revision; trade rate Rs 31,078.83. Group: PD-L1 inhibitor (immunotherapy). No other manufacturer of this salt and strength is listed here yet. Handling/counselling: IV infusion in hospital only; store at 2-8 C, do not freeze. Schedule H - supply only to licensed buyers and dispense only on prescription.

Available at wholesale price for chemists, retailers and distributors on WholesaleChemist.